CytoDyn (CYDY) Interest & Investment Income (2010 - 2026)
CytoDyn's Interest & Investment Income came in at $54,000 for fiscal Q1 2027 (quarter ended Aug 31, 2026), down 42.6% from $94,000 a year earlier and down 40.7% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Interest & Investment Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Aug 31, 2026, CytoDyn reported Interest & Investment Income of $217,000, down 59.3% year-over-year; for FY2026 (ended May 31, 2026), it was $257,000, down 54.5% from FY2025.
- Interest & Investment Income carries a five-year compound annual growth rate of 164.1% (FY2021 to FY2026).
- Going back by fiscal year, Interest & Investment Income was $565,000 in FY2025 (+160.4%) and $217,000 in FY2024.
- The five-year range for quarterly Interest & Investment Income is $15,000 (fiscal Q3 2026) to $173,000 (fiscal Q3 2025).
- Year-over-year, Interest & Investment Income has declined for five consecutive quarters, with an average decline of 49.2% over the last five quarters.
- Business Quant data shows CYDY's Interest & Investment Income at $91,000 (Q4 2026), $15,000 (Q3 2026) and $57,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 54,000.00 |
| May 31, 2026 | 91,000.00 |
| Feb 28, 2026 | 15,000.00 |
| Nov 30, 2025 | 57,000.00 |
| Aug 31, 2025 | 94,000.00 |
| May 31, 2025 | 124,000.00 |
| Feb 28, 2025 | 173,000.00 |
| Nov 30, 2024 | 142,000.00 |
| Aug 31, 2024 | 126,000.00 |
| May 31, 2024 | 21.85 Mn |
| Feb 29, 2024 | -8.51 Mn |
| Nov 30, 2023 | -6.17 Mn |
| Aug 31, 2023 | 6.96 Mn |
| May 31, 2023 | -14.86 Mn |
| Feb 28, 2023 | -9.78 Mn |
| Nov 30, 2022 | -3.33 Bn |
| Aug 31, 2022 | -11.28 Mn |
| May 31, 2022 | -5.07 Mn |
| Feb 28, 2022 | -21.89 Mn |
| Nov 30, 2021 | -14.76 Mn |
API Access
CytoDyn Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();